
HCPLive Five - Dermatology Updates at AAAAI/WAO 2025
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key dermatology updates from the 2025 American Academy of Allergy, Asthma, and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress.
With thousands of attendees from around the world, the AAAAI/WAO Joint Congress 2024 in San Diego, California, reaffirmed its role as a premier event in allergy, asthma, immunology, and dermatology. The conference featured hundreds of new abstracts and late-breaking studies, offering critical insights into emerging treatments, disease mechanisms, and patient care strategies.
As part of our on-site coverage, the HCPLive Allergy team reported live from San Diego, conducting expert interviews and capturing key sessions. In this edition of the HCPLive Five, we highlight our video interviews, including discussions on novel biologics for severe asthma, advancements in food allergy immunotherapy, and high-impact clinical trials presented at the meeting.
In this video, Amy Eapen, MD, an allergist-immunologist at Henry Ford Health System, discussed her research that found that distinct cord-blood DNA methylation (DNAm) patterns are associated with a risk of early-onset atopic dermatitis by 2 years old. Investigators identified 16 differentially methylated regions linked to early-onset atopic dermatitis.
Related to this article








